1 ML alirocumab 150 MG/ML Prefilled Syringe
- RxCUI
- 1659165
- RxNorm name
- 1 ML alirocumab 150 MG/ML Prefilled Syringe
- Display name
- 1 ML alirocumab 150 MG/ML Prefilled Syringe
- Full name
- 1 ML alirocumab 150 MG/ML Prefilled Syringe
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:56
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125559 | Praluent | alirocumab | 351(a) | Rx | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Praluent | ALIROCUMAB | Sanofi-Aventis U.S. LLC | 446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4 | 2026-07-07 | Warnings, Adverse reactions | 1659165 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4 | alirocumab 150 MG in 1 ML Prefilled Syringe [PSN] · 1 ML alirocumab 150 MG/ML Prefilled Syringe [SCD] | 2 | 33 | These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015 | 20251023 |